The Institute of Human Virology (IHV), a branch of the University of Maryland School of Medicine, recently accepted a $24.5 million grant for the next five years to show how comprehensive treatment programs for HIV/AIDS can fight the epidemic.
The grant, which was given from the Centers for Disease Control and Prevention (CDC) via the U.S. President’s Emergency Plan for AIDS Relief, obligates the IHV to coordinate with the government of Botswana to fight the current HIV/AIDS epidemic taking place there.
"This new partnership between our Institute and the government of Botswana is a credit to the work IHV's Clinical Division carries out internationally under the leadership of my colleague and fellow IHV co-founder, Dr. Robert Redfield," Robert Gallo with the University of Maryland School of Medicine said. "We look forward to partnering with Botswana, as we have done in nine other nations through PEPFAR funding, to continue putting the first real dent in the global AIDS pandemic."
Redfield said if any country can reach HIV epidemic control goals, it is Botswana, where the country's leadership is heavily invested in improving the health of its citizens and was one of the first countries to provide HIV antiretroviral treatment for its citizens.
"We hope this new collaboration will lead to Botswana becoming the first country to reach HIV epidemic control status," Deus Bazira Mubangizi with the University of Maryland School of Medicine said. "As the main partner to the government of Botswana in the field of HIV/AIDS, the Institute of Human Virology/University of Maryland has the opportunity to showcase a successful and sustainable model for HIV epidemic control, achieved through cooperation between an American academic institution and a foreign government."